Literature DB >> 2320113

Megakaryocytic and erythrocytic lineages share specific transcription factors.

P H Romeo1, M H Prandini, V Joulin, V Mignotte, M Prenant, W Vainchenker, G Marguerie, G Uzan.   

Abstract

Erythroid-specific genes contain binding sites for NF-E1 (also called GF-1 and Eryf-1; refs 1-3 respectively), the principal DNA-binding protein of the erythrocytic lineage. NF-E1 expression seems to be restricted to the erythrocytic lineage. A closely related (if not identical) protein is found in both a human megakaryocytic cell line and purified human megakaryocytes; it binds to promoter regions of two megakaryocytic-specific genes. The binding sites and partial proteolysis profile of this protein are indistinguishable from those of the erythroid protein; also, NF-E1 messenger RNA is the same size in both the megakaryocytic and erythroid cell lines. Furthermore, point mutations that abolish binding of NF-E1 result in a 70% decrease in the transcriptional activity of a megakaryocytic-specific promoter. We also find that NF-E2, another trans-acting factor of the erythrocytic lineage, is present in megakaryocytes. Transcriptional effects in both lineages might then be mediated in part by the same specific trans-acting factors. Our data strengthen the idea of a close association between the erythrocytic and the megakaryocytic lineages and could also explain the expression of markers specific to the erythrocytic and megakaryocytic lineages in most erythroblastic and megakaryoblastic permanent cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320113     DOI: 10.1038/344447a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  96 in total

1.  An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice.

Authors:  M A McDevitt; Y Fujiwara; R A Shivdasani; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein.

Authors:  P A Ney; B P Sorrentino; C H Lowrey; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

3.  Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells.

Authors:  Clare Heyworth; Stella Pearson; Gillian May; Tariq Enver
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

4.  GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors.

Authors:  Kenji Kitajima; Masaaki Masuhara; Takumi Era; Tariq Enver; Toru Nakano
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

5.  Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors.

Authors:  Xun Wang; John D Crispino; Danielle L Letting; Minako Nakazawa; Mortimer Poncz; Gerd A Blobel
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

6.  Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements.

Authors:  M Walters; D I Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

7.  Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins.

Authors:  Hiromi Yamazaki; Fumiki Katsuoka; Hozumi Motohashi; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

8.  A rapid test for V(D)J recombinase activity.

Authors:  S Kallenbach; M Goodhardt; F Rougeon
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

9.  Comparative sequence analysis of mammalian factor IX promoters.

Authors:  C P Pang; M Crossley; G Kent; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

10.  The SCL gene is formed from a transcriptionally complex locus.

Authors:  P D Aplan; C G Begley; V Bertness; M Nussmeier; A Ezquerra; J Coligan; I R Kirsch
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.